XKRX:950140 (USA)
Â
Shs Korea Depositary Receipts Repr 1 Sh - Rule 903 of Reg S
â‚©
6770.00
(-0.15%)
Jan 14
Business Description
Englewood Lab Inc
NAICS : 322291
SIC : 2676
ISIN : KR8840110108
Share Class Description:
XKRX:950140: Shs Korea Depositary Receipts Repr 1 Sh - Rule 903 of Reg SCompare
Compare
Traded in other countries / regions
950140.Korea IPO Date
2016-10-14Description
Englewood Lab Inc is engaged in providing contract manufacturing services for skin care products. It also provides testing services, and scale-up & piloting. It is engaged in identifying new raw ingredients, molecules, patented technologies, new textures and delivery systems.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1 | |||||
| Equity-to-Asset | 0.7 | |||||
| Debt-to-Equity | 0.24 | |||||
| Debt-to-EBITDA | 1.13 | |||||
| Interest Coverage | 27.92 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.99 | |||||
| Beneish M-Score | -0.87 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 15.2 | |||||
| 3-Year EBITDA Growth Rate | 49.7 | |||||
| 3-Year EPS without NRI Growth Rate | 74.3 | |||||
| 3-Year FCF Growth Rate | 76.7 | |||||
| 3-Year Book Growth Rate | 23.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.35 | |||||
| 9-Day RSI | 40.02 | |||||
| 14-Day RSI | 40.1 | |||||
| 6-1 Month Momentum % | -66.88 | |||||
| 12-1 Month Momentum % | -52.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.06 | |||||
| Quick Ratio | 2.17 | |||||
| Cash Ratio | 0.7 | |||||
| Days Inventory | 95.55 | |||||
| Days Sales Outstanding | 124.84 | |||||
| Days Payable | 41.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.47 | |||||
| Dividend Payout Ratio | 0.13 | |||||
| 5-Year Yield-on-Cost % | 1.47 | |||||
| Shareholder Yield % | 0.29 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 21.86 | |||||
| Operating Margin % | 11.67 | |||||
| Net Margin % | 7.55 | |||||
| FCF Margin % | -0.27 | |||||
| ROE % | 12.1 | |||||
| ROA % | 8.41 | |||||
| ROIC % | 12.34 | |||||
| 3-Year ROIIC % | 40.36 | |||||
| ROC (Joel Greenblatt) % | 19.84 | |||||
| ROCE % | 17.46 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 9.05 | |||||
| Forward PE Ratio | 3.3 | |||||
| PE Ratio without NRI | 9.06 | |||||
| Price-to-Owner-Earnings | 14.67 | |||||
| PS Ratio | 0.69 | |||||
| PB Ratio | 1.07 | |||||
| Price-to-Tangible-Book | 1.07 | |||||
| Price-to-Operating-Cash-Flow | 28.16 | |||||
| EV-to-EBIT | 5.94 | |||||
| EV-to-EBITDA | 4.98 | |||||
| EV-to-Revenue | 0.69 | |||||
| EV-to-FCF | -256 | |||||
| Price-to-Projected-FCF | 1.02 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.36 | |||||
| Price-to-Graham-Number | 0.66 | |||||
| Price-to-Net-Current-Asset-Value | 1.74 | |||||
| Earnings Yield (Greenblatt) % | 16.83 | |||||
| FCF Yield % | -0.4 | |||||
| Forward Rate of Return (Yacktman) % | 22.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Englewood Lab Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 195,921.733 | ||
| EPS (TTM) (â‚©) | 748 | ||
| Beta | 0.4 | ||
| Volatility % | 96.9 | ||
| 14-Day RSI | 40.1 | ||
| 14-Day ATR (â‚©) | 311.243596 | ||
| 20-Day SMA (â‚©) | 6954.5 | ||
| 12-1 Month Momentum % | -52.86 | ||
| 52-Week Range (â‚©) | 6410 - 28300 | ||
| Shares Outstanding (Mil) | 19.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Englewood Lab Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Englewood Lab Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Englewood Lab Inc Frequently Asked Questions
What is Englewood Lab Inc(XKRX:950140)'s stock price today?
The current price of XKRX:950140 is â‚©6770.00. The 52 week high of XKRX:950140 is â‚©28300.00 and 52 week low is â‚©6410.00.
When is next earnings date of Englewood Lab Inc(XKRX:950140)?
The next earnings date of Englewood Lab Inc(XKRX:950140) is .
Does Englewood Lab Inc(XKRX:950140) pay dividends? If so, how much?
The Dividend Yield %  of Englewood Lab Inc(XKRX:950140) is 1.47% (As of Today), Highest Dividend Payout Ratio of Englewood Lab Inc(XKRX:950140) was 0.13. The lowest was 0.1. And the median was 0.1. The  Forward Dividend Yield % of Englewood Lab Inc(XKRX:950140) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers